We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




No Evidence of Improved Survival Rates Seen with Heart Ultrasound before Elective Surgery

By HospiMedica International staff writers
Posted on 30 Aug 2011
A new study has found no evidence that patients who had undergone heart ultrasound before major surgery had improved survival rates one month or one year after their operation. More...


Some groups of patients actually had worse survival rates, according to Dr. Duminda Wijeysundera, a scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences (Toronto, ON, Canada). His study, published June 30, 2011, in the British Medical Journal, adds to a growing body of evidence that echocardiograms may not be helpful in predicting which patients are likely to have complications after major surgery and therefore require more specialized care.

“These findings have important implications, especially since thousands of people undergo surgery around the world every day,” said Dr. Wijeysundera, who is also an anesthesiologist at Toronto General Hospital. “Given that echocardiography may actually cause harm, physicians should reconsider its role for patients undergoing elective surgery. This study also highlights the importance of rigorously evaluating how tests are used in medicine and the fact that more testing is not always better.”

An echocardiogram (ECHO) uses sound waves to create a picture of the heart, showing the shape, texture and movement of heart valves as well as the size of the heart chambers and how well they are working. Dr. Wijeysundera found that 15% of the almost 265,000 Ontario residents who underwent major surgery between 1999 and 2008 had echocardiograms beforehand. That makes the echocardiogram one of the most commonly ordered preoperative tests. In spite of its common use, there was no evidence that the patients who had echocardiograms had improved survival at one month or one year after surgery.

Some groups of patients appear to do worse if they had undergone echocardiography. If a patient had two or fewer risk factors for postoperative cardiac complications and had not undergone cardiac stress testing, having an echocardiogram was associated with a higher chance of dying within one year after surgery. Risk factors could include such conditions as diabetes, kidney disease or a history of heart disease.

Dr. Wijeysundera and his colleagues have previously shown that if patients had at least one risk factor for postoperative cardiac complications, they had better survival after surgery if they had undergone stress testing before their operation. In spite of these better outcomes with stress testing, physicians in Ontario are 50% more likely to order an echocardiogram before surgery, possibly because they are often easier to order quickly.

Dr. Wijeysundera reported that there are some possible reasons for these findings. Since echocardiograms do not perform that well in differentiating between high-risk and low-risk patients, physicians may have been incorrectly reassured that some high-risk patients could safely undergo surgery with no additional specialized care.

Moreover, some physicians may have incorrectly thought that some low-risk patients needed specialized care and therefore given them unnecessary and potentially harmful interventions. “If echocardiography results in patients having a better chance of surviving after major surgery, its increased use is justified,” Dr. Wijeysundera concluded. “If it does not, the relatively common use of echocardiography represents an unnecessary healthcare cost that may also unnecessarily delay scheduled surgeries.”

Related Links:
Li Ka Shing Knowledge Institute of St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences





Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.